Physician profile
Jeff Lin
NPI 1629235783
$30,000.24
in general payments reported to CMS, 2019-2025
22 companies · $7,169 in 2025
The $7,169 reported for 2025 was more than what 89% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,629 · 2020: $5,835 · 2021: $200 · 2022: $3,870 · 2023: $1,590 · 2024: $9,707 · 2025: $7,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $1,278 · Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,800.00 |
| Travel and Lodging | $1,277.87 |
| Food and Beverage | $388.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $16,800.00 | 2024-2025 | |
| Medical Device Business Services, INC. | $4,594.08 | 2019-2023 | Enseal |
| Intuitive Surgical, INC. | $3,145.14 | 2019-2024 | |
| Glaxosmithkline, LLC. | $2,058.84 | 2020-2025 | Bexsero, Pediarix |
| Ethicon Endo-Surgery INC. | $1,250.00 | 2022 | |
| Conmed Corporation | $1,237.25 | 2019-2022 | |
| Boston Scientific Corporation | $265.81 | 2019-2025 | General - Pain Management |
| Aspira Women'S Health INC | $113.97 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $101.16 | 2022-2023 | Lynparza |
| Dysis Medical, INC. | $65.25 | 2020 | |
| Davol INC. | $61.21 | 2019 | |
| Ethicon US, LLC | $56.42 | 2020-2021 | |
| Abbvie INC. | $43.82 | 2020-2021 | |
| Medtronic, INC. | $42.13 | 2023 | Sonicision |
| Myriad Genetic Laboratories, INC. | $31.57 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $27.85 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.63 | 2019 | |
| Hologic Sales and Service, LLC | $19.78 | 2021 | |
| Merck Sharp & Dohme LLC | $18.64 | 2019 | |
| Olympus America INC. | $16.87 | 2021 | |
| Covidien Lp | $15.30 | 2020 | |
| Prescient Surgical | $14.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.